Skip to main content
Year archive

Gentian Diagnostics ASA — 2025 filings

All 56 regulatory filings released by Gentian Diagnostics ASA (GENT) in 2025, sourced directly from the official regulator.

56 Filings
2025 Period
2025 filings (56)
Filing Released Lang
Gentian Diagnostics: Update on NT-proBNP
Regulatory Filings
2025-12-18 English
Gentian Diagnostics presents at the DNB Nordic Healthcare Conference - Attachment: Gentian Diagnostics Nov 25 2025 company presentation DNB.pdf
Investor Presentation
2025-11-25 English
Gentian Diagnostics presents at the DNB Nordic Healthcare Conference
Report Publication Announcement
2025-11-25 English
Financial calendar
Report Publication Announcement
2025-11-11 English
Mandatory notification of trade - Attachment: MH_20251027_KRT1500.pdf
Director's Dealing
2025-10-28 Norwegian
Mandatory notification of trade
Director's Dealing
2025-10-28 English
Gentian Diagnostics: Study Confirms the Value of Calprotectin in Early Detection of Neonatal Infections and Sepsis - Attachment: jENScongress_press release.pdf
Regulatory Filings
2025-10-23 English
Gentian Diagnostics: Study Confirms the Value of Calprotectin in Early Detection of Neonatal Infections and Sepsis
Regulatory Filings
2025-10-23 English
Gentian Diagnostics: Third quarter 2025 report - Attachment: GDASA Q3 25 presentation.pdf
Investor Presentation
2025-10-23 English
Gentian Diagnostics: Third quarter 2025 report - Attachment: GDASA Interim report 3Q 2025.pdf
Interim / Quarterly Report Q3 2025
2025-10-23 English
Gentian Diagnostics: Third quarter 2025 report
Earnings Release Q3 2025
2025-10-23 English
Gentian Diagnostics: Invitation to presentation of third quarter results
Report Publication Announcement
2025-10-16 English
Gentian Diagnostics presents at the Pareto Securities Healthcare conference - Attachment: GDASA Pareto Healthcare September 2025.pdf
Investor Presentation
2025-09-16 English
Gentian Diagnostics presents at the Pareto Securities Healthcare conference
Report Publication Announcement
2025-09-16 English
Gentian Diagnostics: Second quarter 2025 report - Attachment: GDASA Interim report 2Q 2025.pdf
Interim / Quarterly Report Q2 2025
2025-07-10 English
Gentian Diagnostics: Second quarter 2025 report - Attachment: GDASA Q2 25 presentation.pdf
Investor Presentation
2025-07-10 English
Gentian Diagnostics: Second quarter 2025 report
Earnings Release H1 2025
2025-07-10 English
Gentian Diagnostics: Invitation to presentation of second quarter results
Report Publication Announcement
2025-07-03 English
Flaggemelding Gentian Diagnostics ASA
Major Shareholding Notification
2025-06-02 Norwegian
Disclosure of shareholding
Director's Dealing
2025-05-23 English
Disclosure of large shareholding
Major Shareholding Notification
2025-05-22 English
Mandatory notification of trade
Director's Dealing
2025-05-08 Norwegian
Mandatory notification of trade
Major Shareholding Notification
2025-05-08 English
Gentian Diagnostics: Ex dividend NOK 0.40 today
Notice of Dividend Amount
2025-05-07 English
Gentian Diagnostics: First quarter 2025 report
Investor Presentation
2025-05-07 English
Gentian Diagnostics: First quarter 2025 report
Earnings Release Q1 2025
2025-05-07 English
Gentian Diagnostics: First quarter 2025 report
Earnings Release Q1 2025
2025-05-07 English
Gentian Diagnostics: Minutes from Annual General Meeting
AGM Information
2025-05-06 Norwegian
Gentian Diagnostics: Minutes from Annual General Meeting
AGM Information
2025-05-06 English
Gentian Diagnostics: Invitation to presentation of first quarter results
Report Publication Announcement
2025-04-30 English
Gentian Diagnostics: Notice of annual general meeting
AGM Information
2025-04-11 English
Gentian Diagnostics: Notice of annual general meeting
AGM Information
2025-04-11 English
Mandatory notification of trade
Director's Dealing
2025-04-07 English
Mandatory notification of trade
Director's Dealing
2025-04-07 English
Gentian Diagnostics strengthens commercial capabilities with key appointments
Board/Management Information
2025-03-28 English
Correction: Gentian Diagnostics: Annual report 2024
Annual Report (ESEF) FY 2024
2025-03-21 English
Correction: Gentian Diagnostics: Annual report 2024
Annual Report FY 2024
2025-03-21 English
Correction: Gentian Diagnostics: Annual report 2024
Report Publication Announcement FY 2024
2025-03-21 English
Gentian Diagnostics: Annual report 2024
Annual Report (ESEF) FY 2024
2025-03-21 English
Gentian Diagnostics: Annual report 2024
Annual Report FY 2024
2025-03-21 English
Gentian Diagnostics: Annual report 2024
Report Publication Announcement FY 2024
2025-03-21 English
Gentian Diagnostics Receives Notice of Allowance for NT-proBNP Assay Patent in Japan
Regulatory Filings
2025-03-19 English
Gentian Diagnostics: Key information relating to the proposed cash dividend
Notice of Dividend Amount
2025-03-12 English
Gentian Diagnostics and Beckman Coulter Partner to Launch Gentian GCAL® Calprotectin Immunoassay
Regulatory Filings
2025-03-10 English
Gentian Diagnostics and Beckman Coulter Partner to Launch Gentian GCAL® Calprotectin Immunoassay
Regulatory Filings
2025-03-10 English
Mandatory notification of trade
Director's Dealing
2025-03-03 Norwegian
Mandatory notification of trade
Director's Dealing
2025-03-03 English
Notification of trade
Director's Dealing
2025-03-03 Norwegian
Notification of trade
Director's Dealing
2025-03-03 Norwegian
Notification of trade
Major Shareholding Notification
2025-03-03 English
Disclosure of large shareholding in Gentian Diagnotics ASA
Major Shareholding Notification
2025-03-03 English
Disclosure of shareholdings – Holta Invest AS
Major Shareholding Notification
2025-03-03 English
Gentian Diagnostics: Fourth quarter 2024 report
Investor Presentation
2025-02-12 English
Gentian Diagnostics: Fourth quarter 2024 report
Earnings Release Q4 2024
2025-02-12 English
Gentian Diagnostics: Fourth quarter 2024 report
Earnings Release Q4 2024
2025-02-12 English
Gentian Diagnostics: Invitation to presentation of fourth quarter results
Report Publication Announcement
2025-02-05 English